Does Medicare Cover GLP-1 Drugs for Weight Loss in 2026?
Medicare GLP-1 coverage 2026 update: eligible Part D beneficiaries may be able to access select weight-management drugs through the temporary Medicare GLP-1 Bridge for a $50 copay if they meet the program and prior-authorization requirements.
What Is the Medicare GLP-1 Bridge Program?
The Medicare GLP-1 Bridge is a temporary program run by Medicare (CMS) that gives eligible Part D members access to certain weight-loss medications at a reduced cost. The program runs from July 1, 2026 through December 31, 2027 and is available in all 50 states and U.S. territories.
The Medicare GLP-1 Bridge is a temporary CMS demonstration for certain people enrolled in eligible Part D coverage. It is not the same as ordinary Part D formulary coverage, and approval requires prior authorization.
What Does It Cost?
Eligible members pay a flat $50 copay per fill. A few things worth knowing about how that copay works:
- Your Part D deductible does not apply
- The $50 does not count toward your out-of-pocket maximum
- Low-income subsidy (LIS/Extra Help) does not apply to this program
Which Medications Are Covered?
The program currently covers three GLP-1 medications when used specifically for weight loss:
- Foundayo (all formulations)
- Wegovy (injection and tablet, all formulations)
- Zepbound KwikPen only
Note: The single-dose vial and single-dose pen versions of Zepbound are not covered under this program.
Who Qualifies?
The GLP-1 Bridge was designed for Medicare Part D members who are using these medications for weight loss only, not for other conditions.
You do not qualify for the Bridge program if your GLP-1 prescription is for any of the following:
- Type 2 diabetes
- Obstructive sleep apnea
- Noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH)
Those conditions are already covered under standard Part D benefits, so if you have one of those diagnoses, you should continue getting your medication through your regular Part D plan.
The Bottom Line
If you are on Medicare Part D and taking a GLP-1 medication solely for weight management, the Bridge program could significantly lower your monthly cost to just $50. If your prescription is tied to a condition like diabetes or sleep apnea, your coverage stays exactly where it is through your Part D plan.
For the full details, visit the official CMS page: cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
Or Contact the Medicare Support Services Team at 940-382-4700
